"10.1371_journal.pone.0026152","plos one","2011-10-10T00:00:00Z","Jiuping Ji; Robert J Kinders; Yiping Zhang; Larry Rubinstein; Shivaani Kummar; Ralph E Parchment; Joseph E Tomaszewski; James H Doroshow","National Clinical Target Validation Laboratory, National Cancer Institute at Frederick, Frederick, Maryland, United States of America; Laboratory of Human Toxicology and Pharmacology, Applied/Developmental Research Support Directorate, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland, United States of America; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, United States of America; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America","Conceived and designed the experiments: JJ RJK SK REP JET JHD. Performed the experiments: YZ. Analyzed the data: YZ JJ RJK LR REP JET JHD. Contributed reagents/materials/analysis tools: JJ RJK LR SK JET JHD. Wrote the paper: JJ RJK. Enrolled patients: SK.","The authors have read the journals policy and have the following conflicts: Dr. Kinders consults for Trevigen and owns stock in Abbott Laboratories.","2011","10","Jiuping Ji","JJ",8,TRUE,6,1,7,2,TRUE,TRUE,FALSE,0,NA,FALSE
